report
Global cardiac monitoring market to be valued at $13.24b by 2030
Global cardiac monitoring market to be valued at $13.24b by 2030
By end user, the hospital segment accounts for the largest market share.
Smart hospitals market to surpass $161.6b by 2033
Thanks to healthcare automation, AI, and IoT-based medical devices.
7MM COPD market to hit $30.2b in 2033
Triple therapy inhalers are expected to account for 11.3% of the total market.
What drives the shoulder arthroplasty field?
Improved fixation techniques are helping prevent failures and reduce repeat surgeries.
What to expect with APAC’s elder care products market?
The global market is expected to reach $45b by the end of 2032.
Australia’s PET imaging agents market to see 2% CAGR growth until 2033
The sector’s expansion is driven by a surge in prostate cancer cases.
Singapore’s oncology landscape to advance with histotripsy technology
The approach is an ultrasound-based technique that offers a pain-free alternative.
Global injectible drug delivery devices market to hit $317.2b by 2029
Biologic drug development is driving the demand for advanced injectable delivery systems.
China’s mechanical heart valves market to reach $50m in 2033
The country accounts for about 50% of the market share in the Asia Pacific.
7MM regulatory T-cell market to grow over 57% CAGR by 2034
Currently, no Treg-based therapies are approved.
India's healthcare expenditure to rise to 5% of GDP by 2030
The growth is driven by structural improvements within the sector.
What can we expect from Turkiye’s health sector?
Persistent economic instability remains a key constraint.
Cytogenetics market to be valued at $5.5b by 2031
Its growth is attributed to the rising prevalence of genetic disorders and cancer.
Healthcare payers lag in digital maturity: report
AI solutions could cut costs and increase revenue for payers.
Alzheimer's drugs market to be valued at $16.43b by 2033
Technologies like genomics, neuroimaging, and biomarker analysis drive growth.
Global infertility treatment devices to hit $2.5b by 2032
Its growth is attributed to ongoing innovation, particularly in AI integration.
Global medical radioisotopes market to be valued at $1.38b by 2034
Thanks to rising applications in diagnostics and therapeutics.